diabetes - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin resistance in peripheral tissues leads to decreased glucose uptake, forcing the pancreas to compensate by producing more insulin, eventually causing beta-cell dysfunction and reduced insulin secretion.
• Secondary mechanism: Chronic hyperglycemia triggers advanced glycation end-products (AGEs) formation, which disrupts cellular function and promotes inflammation, vascular damage, and oxidative stress.
• Key complication: Sustained vascular damage from AGEs and oxidative stress results in microvascular complications like diabetic retinopathy, nephropathy, and neuropathy, alongside macrovascular issues such as increased risk for cardiovascular disease.
Patient Profile
Demographics:
62-year-old male, retired school principal
History:
• Key past medical history: Type 2 diabetes diagnosed 15 years ago, hypertension, hyperlipidemia, diabetic neuropathy, chronic kidney disease stage 3
• Current medications: Metformin, insulin glargine, lisinopril, atorvastatin, gabapentin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe foot ulcer with signs of infection
• Key symptoms: Persistent fatigue, polyuria, blurred vision, tingling in hands and feet, difficulty breathing
• Vital signs: Blood pressure 180/110 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101.2°F (38.4°C), blood glucose 350 mg/dL
Section 1
Initial assessment findings reveal critical insights into the patient's current condition. Upon comprehensive examination, the severe foot ulcer is noted to be approximately 5 cm in diameter with purulent discharge and a foul odor, indicative of a possible bacterial infection. The surrounding tissue is erythematous and warm to the touch, suggesting cellulitis. Peripheral pulses in the affected limb are weak, and capillary refill is delayed, raising concerns about peripheral vascular disease. The patient's respiratory distress is evident through the use of accessory muscles and the presence of coarse crackles upon auscultation, hinting at possible pulmonary edema or underlying cardiac involvement. Neurologically, the patient reports worsening tingling and numbness in his extremities, primarily in the lower limbs, consistent with diabetic neuropathy progression.
New diagnostic results provide further insight into the patient's complex condition. A complete blood count reveals leukocytosis with a white blood cell count of 15,000/mm^3, supporting the suspected infection. Serum creatinine levels have increased to 2.5 mg/dL, indicative of worsening renal function, possibly exacerbated by acute kidney injury on chronic kidney disease. The patient's hemoglobin A1c is markedly elevated at 10.5%, reflecting poor long-term glycemic control. Arterial blood gas analysis shows a pH of 7.30, PaCO2 of 50 mmHg, and HCO3- of 18 mEq/L, indicative of a mixed metabolic and respiratory acidosis, necessitating prompt intervention. An ECG reveals sinus tachycardia with signs of left ventricular hypertrophy, reinforcing the need for cardiology consultation to address potential heart failure.
These findings guide the immediate medical priorities and interventions. The patient requires aggressive management of his infection with antibiotics, tailored to the culture and sensitivity results. Fluid management must be carefully balanced due to renal impairment and potential heart failure. Glycemic control needs urgent optimization, requiring adjustments in insulin therapy. The interdisciplinary team must address the patient's cardiovascular risks, with potential modifications to antihypertensive and lipid-lowering therapy. These complex interrelated conditions demand seamless coordination across specialties, setting the stage for ongoing assessment and treatment adjustments as the patient's clinical picture evolves.
Section 2
After initiating treatment, the patient's condition presents new challenges that require immediate attention. Within 24 hours of antibiotic therapy and careful fluid management, the patient's vital signs show a concerning trend. The patient's temperature has spiked to 39.5°C (103.1°F), suggesting a potential worsening or resistant bacterial infection, necessitating a review of antibiotic coverage. Blood pressure has dropped to 90/60 mmHg, despite cautious administration of fluids, raising the alarm for possible septic shock. Heart rate remains elevated at 120 beats per minute, with episodes of premature atrial contractions noted on continuous cardiac monitoring, indicating increased cardiac strain. Respiratory rate has increased to 28 breaths per minute, and oxygen saturation has dropped to 88% on room air, which now requires supplemental oxygen. These changes signal a potential systemic inflammatory response syndrome (SIRS) and highlight the need for rapid intervention to prevent further deterioration.
Laboratory results further complicate the clinical picture. A repeat complete blood count shows a rising white blood cell count now at 18,500/mm^3, with a left shift indicative of an ongoing or worsening infection. C-reactive protein levels are markedly elevated at 150 mg/L, supporting an inflammatory process. Blood cultures are pending, but the initial sensitivity results from the wound culture suggest resistance to the empirical antibiotic regimen, prompting an urgent consultation with infectious disease specialists for alternative antimicrobial strategies. Kidney function continues to decline, with serum creatinine now at 3.0 mg/dL and blood urea nitrogen at 45 mg/dL, necessitating discussions regarding renal replacement therapy options.
These developments require a recalibration of the treatment plan. The interdisciplinary team must prioritize stabilizing the patient’s hemodynamics and addressing potential septic shock. Intensified monitoring and potential escalation to vasopressor support might be necessary. The team should also consider revisiting the patient's insulin regimen, as stress-induced hyperglycemia may further complicate metabolic control. This evolving clinical scenario demands that healthcare providers remain vigilant, employing advanced clinical reasoning to anticipate and mitigate new complications, while preparing for potential critical care interventions as the patient's journey progresses.
Section 3
New Diagnostic Results
Amidst the escalating crisis, the healthcare team receives crucial new diagnostic information that could pivot the patient’s management strategy. The blood cultures return positive for a multi-drug resistant strain of Klebsiella pneumoniae, explaining the patient's lack of response to the initial broad-spectrum antibiotic regimen. This pathogen is notoriously challenging to treat in the setting of diabetes due to its propensity for rapid dissemination and resistance. The infectious disease specialists advocate for a swift transition to a more targeted antibiotic regimen, recommending a combination of meropenem and colistin, given the resistance profile. This change underscores the urgency of tailoring antimicrobial therapy to combat the resistant infection effectively.
Simultaneously, a repeat arterial blood gas analysis reveals a worsening metabolic acidosis, with a pH of 7.28, bicarbonate level of 18 mEq/L, and partial pressure of carbon dioxide (PaCO2) at 32 mmHg. This indicates a significant underlying metabolic derangement, likely driven by a combination of renal impairment, infection-induced stress, and possible lactic acidosis from tissue hypoperfusion. The presence of an increased anion gap further supports the suspicion of lactic acidosis. This metabolic disturbance compels the healthcare team to consider adjunctive therapies such as sodium bicarbonate infusion to buffer the acidosis, while simultaneously addressing the root causes to prevent further deterioration.
Moreover, an abdominal ultrasound performed to evaluate the etiology of the renal impairment reveals bilateral hydronephrosis, suggesting obstructive uropathy as a contributing factor. This finding necessitates immediate urological consultation to explore potential interventions such as nephrostomy or ureteral stenting to relieve the obstruction and improve renal function. The interdisciplinary team must now integrate these new diagnostic insights into the evolving treatment plan, maintaining a delicate balance between aggressive intervention and the patient’s overall stability. This multifaceted approach is crucial to navigate the complexities of the patient’s condition and guide them towards recovery.
Section 4
Change in Patient Status
Following the implementation of the targeted antibiotic regimen with meropenem and colistin, the healthcare team closely monitors the patient's response. Within 48 hours, there is a slight improvement in the patient's fever curve, with temperatures reducing from a persistent 39.5°C to 38.2°C, suggesting a potential response to the adjusted antimicrobial therapy. However, the patient's overall condition remains precarious as new complications emerge. The patient develops acute respiratory distress, characterized by increased work of breathing, tachypnea with a respiratory rate of 28 breaths per minute, and a declining oxygen saturation level, now at 88% on 4L/min nasal cannula oxygen support. Auscultation reveals diminished breath sounds at the bases, raising concern for possible pulmonary involvement secondary to the disseminated infection or evolving acute respiratory distress syndrome (ARDS).
Concurrently, laboratory tests indicate a significant drop in hemoglobin from 12 g/dL to 9.5 g/dL, coupled with a rising lactate level now at 5 mmol/L, which exacerbates the metabolic acidosis. The drop in hemoglobin suggests a potential gastrointestinal bleed or hemolytic process, necessitating further investigation. The worsening lactic acidosis and hypoxemia prompt the consideration of escalating respiratory support, possibly transitioning to non-invasive ventilation or intubation if the patient's respiratory status continues to decline.
The renal function shows no significant improvement despite the urological intervention, with serum creatinine remaining elevated at 3.5 mg/dL. The persistent renal impairment, combined with the evolving respiratory distress and hematologic instability, signals a complex interplay of systemic infection and multi-organ dysfunction. The interdisciplinary team must now prioritize stabilizing the patient's respiratory status, continue aggressive management of the infection, and further explore the cause of the hematologic changes, all while maintaining vigilance for any additional complications that may arise. This multifaceted clinical picture demands an agile and comprehensive approach to optimize the patient’s trajectory toward recovery.
Section 5
New Diagnostic Results
As the healthcare team grapples with the patient's complex condition, a series of new diagnostic tests are expedited to clarify the underlying causes of the recent clinical deterioration. A chest X-ray reveals bilateral infiltrates consistent with developing acute respiratory distress syndrome (ARDS), confirming the suspicion of pulmonary involvement. This finding aligns with the patient's increased work of breathing and declining oxygen saturation levels, necessitating close monitoring and consideration for escalating respiratory support.
Simultaneously, a computed tomography (CT) scan of the abdomen is conducted to investigate the potential source of the hemoglobin drop. The scan reveals evidence of a small, but active, gastrointestinal bleed in the lower gastrointestinal tract, likely exacerbated by the stress of systemic infection and anticoagulation therapy used to prevent thrombotic complications. This discovery prompts an urgent consult with gastroenterology for potential endoscopic intervention.
Additional laboratory tests return with a concerning elevation in bilirubin levels, rising to 3.2 mg/dL, and a marked increase in reticulocyte count, suggesting a hemolytic process may be contributing to the anemia. The presence of schistocytes on the peripheral blood smear further supports this, indicating possible microangiopathic hemolytic anemia. These findings necessitate a thorough investigation into possible causes such as sepsis-induced disseminated intravascular coagulation (DIC) or a drug-induced hemolytic anemia, which could be contributing to the patient's declining hematologic stability. These new diagnostic insights compel the team to refine their treatment approach, integrating targeted management strategies for both the pulmonary and hematologic complications while continuing aggressive antimicrobial therapy.